Alpha-1 Antitrypsin Deficiency is believed to be diagnosed in only 4% of people who have it. Since it is most often associated with COPD and Bronchiectasis, respiratory therapists can play an important role in its identification and treatment. This online course from the AARC is aimed at significantly improving knowledge of this under-recognized disease.
**Please note that all programs require the participant to view the entire program prior to taking the final quiz and obtaining a course certificate.**
- Explain the pathobiology of Alpha-1 Antitrypsin Deficiency (A1ATD)
- Identify the prevalence of A1ATD
- Identify the clinical manifestations of A1ATD
- Describe the pathogenesis of emphysema and bronchiectasis in A1ATD
- Discuss the genetic link of A1ATD
- Identify the types of testing for A1ATD
- Define COPD and the impact of COPD
- Identify the purpose of COPD disease staging
- Discuss disease management goals for COPD
- Discuss the history, rationale, and controversies for augmentation therapy in A1ATD
- Discuss emerging therapies targeting A1ATD